Herz Und Diabeteszentrum NRW Bad Oeynhausen Universitaetsklinik Der Ruhr-Universitaet Bochum — Clinical Trial Site

39 Registered trials

18 Currently recruiting

Organisation

Herz Und Diabeteszentrum NRW Bad Oeynhausen Universitaetsklinik Der Ruhr-Universitaet Bochum

Location

Bad Oeynhausen, Germany

Identifier

ORG-100016632

Address

Georgstrasse 11, Innenstadt, 32545, Germany

Departments

#2120: Klinik für Allgemeine und Interventionelle Kardiologie/Angiologie
#3474: Klinik für Allgemeine und Interventionelle Kardiologie / Angiologie
2306: Diabeteszentrum Forschung
3474: Klinik für Allgemeine und Interventionelle Kardiologie / Angiologie
7004: Herz- und Diabeteszentrum NRW
Clinic for Diabetology and Endocrinology
Clinic for General and Interventional Cardiology/Angiology
Diabeteszentrum Forschung
endocrinology,diabetology
Herz- und Diabeteszentrum
Herz- und Diabeteszentrum Nordrhein-Westfalen
Herz- und Diabeteszentrum NRW
Herz- und Diabeteszentrum NRW - Bad Oeynhausen - Forschungsleitung Diabeteszentrum
Institute of Anesthesiology and pain therapy
Klinik fuer Diabetologie, Endokrinologie und Gastroenterologie
Klinik für Allgemeine und Interventionelle Kardiologie/Angiologie
Klinik für Allgemeine und Interventionelle Kardiologie/Angiologie
Klinik für Allgemeine und Interventionelle Kardiologie/Angiologie
Klinik für Diabetologie und Endokrinologie
Klinik für Diabetologie und Endokrinologie, Diabeteszentrum
Klinik für Electrophysiologie/Rhythmologie
Klinik für Kinderkardiologie und angeborene Herzfehler
N/A
NA
Nuclear Medicine
Universitätsklinik der Ruhr-Universität Bochum

Clinical trials at this site (39)

Search interface

LIBREXIA-AF A Phase 3 Active-controlled Study of Milvexian for Prevention of Cardioembolic Events in Participants with Atrial Fibrillation Ended

2022-501419-15-00 Atrial Fibrillation 5 2023-08-23
OCEAN(a)-Outcomes – Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction – Outcomes trial Ended

2022-501608-85-00 Cardiovascular disease (atherosclerotic cardiovascular 5 2023-05-09
A Study of Tirzepatide (LY3298176) on the Reduction of Morbidity and Mortality in Adults With Obesity (SURMOUNT- MMO) Ended

2022-501744-15-00 Obesity, Overweight 5 2023-01-23
A multicenter trial assessing the impact of lipoprotein (a) lowering with pelacarsen (TQJ230) on major cardiovascular events in patients wit… Ended

2023-508292-37-00 Cardiovascular Disease 5 2020-03-06
Effects of AZD5004 in adults who are living with obesity or overweight with at least 1 weight-related medical condition Ended

2024-513691-18-00 Participants living with Obesity or Overweight with at 4 2024-12-11
A randomized, multicenter, open-label trial comparing the effectiveness of Inclisiran to bempedoic acid on LDL cholesterol (LDL-C) lowering … Ended

2024-511076-32-00 Hypercholesterolemia 6 2024-06-21
A clinical research study to learn if baxdrostat works at reducing ambulatory blood pressure and is safe for people with high blood pressure… Ended

2023-507640-36-00 Resistant hypertension (rHTN) defined as blood pressure 5 2024-04-29
A study to learn if baxdrostat works at reducing blood pressure and is safe in people with high blood pressure Ended

2023-505499-32-00 Uncontrolled hypertension (uTHN) defined as blood press 5 2024-03-08
A study to learn how well the study treatment finerenone works and how safe it is in people with long-term decrease in the kidneys’ ability … Ended

2022-503024-27-00 Chronic kidney disease associated with type 1 diabetes 5 2024-02-27
A Phase 2 Study of the Effects of Ponsegromab on Health-Related Quality of Life and Safety in Patients With Heart Failure (GARDEN-TIMI 74) Ended

2023-509747-27-00 Heart failure 4 2023-05-18
A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults with Cardiomyopathy Ended

2023-506352-24-00 Non-obstructive Hypertrophic Cardiomyopathy 5 2023-04-13
A multi-center study to evaluate the safety, tolerability and efficacy of TIN816 in patients at risk for acute kidney injury following a car… Ended

2024-511621-64-00 Acute kidney injury 4 2023-01-18
Study to understand if inclisiran is better than a placebo at lowering LDL-cholesterol,is safe and can have an impact on patient quality of … Ended

2024-511263-28-00 Hypercholesterolemia 6 2022-04-08
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CV… Ended

2023-507846-96-00 Type 2 Diabetes Mellitus 5 2020-06-19
Mavacamten Impact on Myocardial Structure in Obstructive Hypertrophic Cardiomyopathy Ended

2022-502316-36-00 Symptomatic Obstructive Hypertrophic Cardiomyopathy 11